title: Monoclonal antibody to lymphocyte function associated antigen-1 improves graft-versus-host disease.
abstract: We previously showed that intestinal tissue expression of lymphocyte function associated antigen-1 is increased in animals with graft-versus-host disease after small-bowel transplantation.
  
  
  OBJECTIVE
  Treatment of rats with monoclonal antibody to lymphocyte function associated antigen-1 after small-bowel transplantation will lessen the severity of graft-versus-host disease.
  
  
  METHODS
  Graft-versus-host disease was created in Lewis X Brown-Norway F1 rats by heterotopic vascularized small-bowel transplantation from Lewis donors. Transplanted rats were treated with either saline or various regimens of monoclonal antibody to lymphocyte function associated antigen-1. Clinical characteristics, weight loss, spleen index, white blood cell counts, native intestinal histology, bowel permeability, and survival were then compared between groups and appropriate sham-operated and lymphocyte function associated antigen-1-treated controls.
  
  
  RESULTS
  Lymphocyte function associated antigen-1-treated rats lost less weight, had larger spleen indexes, more normal white blood cell counts, more normal native intestinal histology, less alteration in bowel permeability, and longer survival than untreated small-bowel transplantation rats.
  
  
  CONCLUSIONS
  In this model of graft-versus-host disease after small-bowel transplantation, monoclonal antibody to lymphocyte function associated antigen-1 treatment decreased the severity of graft-versus-host disease and prolonged rat survival.
authors.affiliation: Department of Surgery, Pennsylvania State University, College of Medicine, The Milton S. Hershey Medical Center, Hershey 17033-0850, USA.
authors.forename: L S
authors.initials: LS
authors.lastname: Poritz
authors.forename: M J
authors.initials: MJ
authors.lastname: Page
authors.forename: A F
authors.initials: AF
authors.lastname: Tilberg
authors.forename: G
authors.initials: G
authors.lastname: Olt
authors.forename: F M
authors.initials: FM
authors.lastname: Ruggiero
authors.forename: W A
authors.initials: WA
authors.lastname: Koltun
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000276:immunology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D007150:Immunohistochemistry; D007408:Intestinal Absorption; D007421:Intestine, Small / Q000473:pathology / Q000637:transplantation; D007958:Leukocyte Count; D016169:Lymphocyte Function-Associated Antigen-1 / Q000032:analysis / Q000276:immunology*; D010539:Permeability; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013154:Spleen / Q000473:pathology; D016042:Transplantation, Heterotopic; D015431:Weight Loss
chemical_list: D000911:Antibodies, Monoclonal; D016169:Lymphocyte Function-Associated Antigen-1